Evidence map›Paper›PMID 21693591›Full record

ArticleJournal of leukocyte biology2011

Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression.

Jerod A Skyberg, Amy Robison, Sarah Golden, Maryclare F Rollins, Gayle Callis, Eduardo Huarte, Irina Kochetkova, Mark A Jutila, David W Pascual

Abstract read
In one paragraph

Article in Journal of leukocyte biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Effect of Concentrated Apple Extract on Experimental Colitis Induced by Acetic Acid.International journal of molecular and cellular medicine · 2017
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jerod A SkybergDepartment of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA.
Amy Robison
Sarah Golden
Maryclare F Rollins
Gayle Callis
Eduardo Huarte
Irina Kochetkova
Mark A Jutila
David W Pascual
Montana State University · US

Funding

CAMs as counter measures against infectious and inflammatory diseaseP01AT004986 · NCCIH · MONTANA STATE UNIVERSITY - BOZEMAN · PI JUTILA, MARK A · 2008 to 2012
$5.9M
NCCIH NIH HHS P01 AT004986NIAID NIH HHS N01 AI040009
6 · The paper itself

Abstract

Human IBD, including UC and Crohn's disease, is characterized by a chronic, relapsing, and remitting condition that exhibits various features of immunological inflammation and affects at least one/1000 people in Western countries. Polyphenol extracts from a variety of plants have been shown to have immunomodulatory and anti-inflammatory effects. In this study, treatment with APP was investigated to ameliorate chemically induced colitis. Oral but not peritoneal administration of APP during colitis induction significantly protected C57BL/6 mice against disease, as evidenced by the lack of weight loss, colonic inflammation, and shortening of the colon. APP administration dampened the mRNA expression of IL-1β, TNF-α, IL-6, IL-17, IL-22, CXCL9, CXCL10, CXCL11, and IFN-γ in the colons of mice with colitis. APP-mediated protection requires T cells, as protection was abated in Rag-1(-/-) or TCRα(-/-) mice but not in IL-10(-/-), IRF-1(-/-), μMT, or TCRδ(-/-) mice. Administration of APP during colitis to TCRα(-/-) mice actually enhanced proinflammatory cytokine expression, further demonstrating a requirement for TCRαβ cells in APP-mediated protection. APP treatment also inhibited CXCR3 expression by TCRαβ cells, but not B or NK cells, in the colons of mice with colitis; however, depletion of CD4(+) or CD8(+) T cells alone did not abolish APP-mediated protection. Collectively, these results show that oral administration of APP protects against experimental colitis and diminishes proinflammatory cytokine expression via T cells.

Indexed as

AnimalsCells, CulturedColitisCytokinesDextran SulfateFemaleHumansInflammation MediatorsMaleMalusMiceMice, Inbred C57BLMice, KnockoutPolyphenolsT-Lymphocyte SubsetsCytokinesDextran SulfateInflammation MediatorsPolyphenols

Identifiers

PMID21693591
PMCPMC3236552
OpenAlexW2145803482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.